Antihypertension Profile During Pregnancy at a Private Hospital in Surabaya

Authors

DOI:

https://doi.org/10.33084/bjop.v8i1.7938

Keywords:

Antihypertensive, Pregnancy, Hospitalization, Inpatient

Abstract

Hypertension during pregnancy, a significant obstetric complication, can lead to severe consequences such as preeclampsia. This study aimed to determine the pattern of antihypertensive medication use, including drug type, route of administration, dosage, and frequency, as well as investigate the relationship between clinical data, including blood pressure and proteinuria, and the use of single or combination antihypertensive therapy in pregnant women with hypertension. A retrospective observational study was conducted on 108 pregnant women with hypertension admitted to the inpatient unit of a private hospital in Surabaya, Indonesia. Data on patient demographics, comorbidities, antihypertensive medications, blood pressure, and proteinuria levels were collected and analyzed. The majority (79.65%) of patients were aged between 20 and 35 years. Common comorbidities included obesity (62.50%), pre-existing hypertension (18.75%), and a history of preeclampsia in previous pregnancies (6.25%). Nifedipine (73.26%) was the most frequently used single antihypertensive medication, followed by methyldopa (23.26%). Combination therapy, primarily nifedipine and methyldopa (92.31%), was commonly employed. Most patients (97.35%) achieved blood pressure control, and 47.79% showed improvement in proteinuria levels. Nifedipine and the combination of nifedipine and methyldopa were the most frequently used antihypertensive medications in this cohort. Most patients achieved blood pressure control, indicating effective management of hypertension during pregnancy. Further studies are warranted to investigate the long-term outcomes and optimize antihypertensive therapy strategies in this population.

Views: 703Downloads: 617

Downloads

Download data is not yet available.

Author Biographies

References

Lukito AA, Harmeiwaty E, Hustrini NM. Konsensus penatalaksanaan hipertensi 2019. Jakarta: Indonesian Society of Hypertension; 2019.

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6):1334-57. DOI: 10.1161/hypertensionaha.120.15026; PMID: 32370572

Bajpai D, Popa C, Verma P, Dumanski S, Shah S. Evaluation and Management of Hypertensive Disorders of Pregnancy. Kidney360. 2023;4(10):1512-25. DOI: 10.34067/kid.0000000000000228; PMCID: PMC10617800; PMID: 37526641

Ekwuazi EK, Chigbu CO, Ngene NC. Reducing maternal mortality in low- and middle-income countries. Case Rep Womens Health. 2023;39:e00542. DOI: 10.1016/j.crwh.2023.e00542; PMCID: PMC10636262; PMID: 37954228

Suparji S, Nugroho HSW, Sunarto S, Prayogi AS. High maternal mortality rate in Indonesia: a challenge to be addressed immediately. PAMJ-One Health. 2024;14:13. DOI: 10.11604/pamj-oh.2024.14.13.44464

Febriyanto EC, Indawati R, Mahmudah, Ama F, Ashari FY. Modeling of Maternal Mortality (MMR) in East Java 2017-2019 Using Panel Regression Approach. J Biometrika Kependudukan. 2023;12(2):177-85. DOI: 10.20473/jbk.v12i2.2023.177-185

Sulistyono A, Joewono HT, Yustinasari, Aditiawarman. Maternal mortality from eclampsia at tertiary referral hospital, Surabaya, Indonesia. Eurasia J Biosci. 2020;14:1709-13.

Ernawaty E, Sri D. Health Expenditure Analysis in Patients with Pregnancy-Labor Complications in Surabaya. Indones J Health Adm. 2022;10(1):3-13. DOI: 10.20473/jaki.v10i1.2022.3-13

Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. DOI: 10.1038/nrdp.2018.14; PMCID: PMC6477925; PMID: 29565029

Awaludin A, Rahayu C, Daud NAA, Zakiyah N. Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis. Healthcare. 2022;10(2):325. DOI: 10.3390/healthcare10020325; PMCID: PMC8872490; PMID: 35206939

Donel S, Novri DA, Hamidy Y, Savira M. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial. F1000Res. 2023;11:1287. DOI: 10.12688/f1000research.125944.2; PMCID: PMC10238817; PMID: 37273965

Hazra PK, Mehta A, Desai B, Pandey U, Mehta KD, Bajpai S, et al. Long-acting nifedipine in the management of essential hypertension: a review for cardiologists. Am J Cardiovasc Dis. 2024;14(6):396-413. DOI: 10.62347/rpmz6407; PMCID: PMC11744219; PMID: 39839565

Snider ME, Nuzum DS, Veverka A. Long-acting nifedipine in the management of the hypertensive patient. Vasc Health Risk Manag. 2008;4(6):1249-57. DOI: 10.2147/vhrm.s3661; PMCID: PMC2663456; PMID: 19337538

Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394(10203):1011-21. DOI: 10.1016/S0140-6736(19)31282-6; PMCID: PMC6857437; PMID: 31378394

Gradman AH, Basile JN, Carter BL, Bakris GL. Combination Therapy in Hypertension. J Clin Hypertens. 2010;13(3):146-54. DOI: 10.1111/j.1751-7176.2010.00397.x; PMCID: PMC8673364; PMID: 21366845

Brown CM, Garovic VD. Drug Treatment of Hypertension in Pregnancy. Drugs. 2014;74(3):283-96. DOI: 10.1007/s40265-014-0187-7; PMCID: PMC4558097; PMID: 24554373

Campbell S, Greenwood M, Prior S, Shearer T, Walkem K, Young S, et al. Purposive sampling: complex or simple? Research case examples. J Res Nurs. 2020;25(8):652-61. DOI: 10.1177/1744987120927206; PMCID: PMC7932468; PMID: 34394687

Chang KJ, Seow KM, Chen KH. Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. Int J Environ Res Public Health. 2023;20(4):2994. DOI: 10.3390/ijerph20042994; PMCID: PMC9962022; PMID: 36833689

Karrar SA, Martingano DJ, Hong PL. Preeclampsia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 34033373

Ernawati, Aditiwarman, Rifdah SN, Sulistyono A. Antihypertensive Choices during Pregnancy in Limited Setting. Pharmacogn J. 2023;15(2):315-8. DOI: 10.5530/pj.2023.15.46

Stason WB, Schmid CH, Niedzwiecki D, Whiting GW, Caubet JF, Luo D, et al. Safety of nifedipine in patients with hypertension: a meta-analysis. Hypertension. 1997;30(1 Pt 1):7-14. DOI: 10.1161/01.hyp.30.1.7; PMID: 9231814

Cífková R. Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview. High Blood Press Cardiovasc Prev. 2023;30(4):289-303. DOI: 10.1007/s40292-023-00582-5; PMCID: PMC10403432; PMID: 37308715

Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis. 2007;49(1):12-26. DOI: 10.1053/j.ajkd.2006.10.014; PMID: 17185142

Marlina Y, Santoso H, Sirait A. Faktor-Faktor Yang Berhubungan Dengan Hipertensi Pada Ibu Hamil di Wilayah Kerja Puskesmas Padang Panyang Kecamatan Kuala Pesisir Kabupaten Nagan Raya. J Healthc Technol Med. 2022; 7(2):1512-25. DOI: 10.33143/jhtm.v7i2.1734

Dewie A, Pont AV, Purwanti A. Hubungan Umur Kehamilan dan Obesitas Ibu Hamil dengan Kejadian Preeklampsia di Wilayah Kerja Puskesmas Kampung Baru Kota Luwuk. Promotif J Kesehatan Masyarakat. 2020;10(1):21–7. DOI: 10.56338/pjkm.v10i1.616

Kepley JM, Bates K, Mohiuddin SS. Physiology, Maternal Changes. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 30969588

Bardja S. Faktor Risiko Kejadian Preeklampsia Berat/Eklampsia pada Ibu Hamil. EMBRIO J Kebidanan. 2020;12(1):18–30. DOI: 10.36456/embrio.v12i1.2351

Silvana R, Ramayanti I, Kurniawan, Ramadhina AD. Hubungan Antara Usia Ibu, Status Gravida, dan Riwayat Hipertensi dengan Terjadinya Preeklampsia. ULIL ALBAB J Ilmiah Multidisiplin. 2023;2(4):1370–5.

Perkumpulan Obstetri dan Ginekologi Indonesia. Pedoman Nasional Pelayanan Kedokteran Diagnosis dan Tata Laksana Preeklamsia. Jakarta: Perkumpulan Obstetri dan Ginekologi Indonesia; 2016.

Hidayati SF, Andarini YD, Marfu’ah N. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Ibu Hamil di Instalasi Rawat Inap RSIA Muslimat Jombang Tahun 2018. Pharmasipha Pharm J Islam Pharm. 2020;4(2):66-73. DOI: 10.21111/pharmasipha.v4i2.4959

Kernaghan D, Duncan AC, McKay GA. Hypertension in pregnancy: a review of therapeutic options. Obstet Med. 2012;5(2):44-9. DOI: 10.1258/om.2011.110061; PMCID: PMC4989617; PMID: 27579135

Lee H, Park MS, Kang MK, Song TJ. Association between Proteinuria Status and Risk of Hypertension: A Nationwide Population-Based Cohort Study. J Pers Med. 2023;13(9):1414. DOI: 10.3390/jpm13091414; PMCID: PMC10533010; PMID: 37763181

Downloads

Published

02/28/2025

Issue

Section

Clinical-Community Pharmacy

Categories

How to Cite

1.
Wiputri OI, Rahma I, Samlan K. Antihypertension Profile During Pregnancy at a Private Hospital in Surabaya. Borneo J Pharm [Internet]. 2025 Feb. 28 [cited 2026 Nov. 18];8(1):25-32. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/7938

Similar Articles

21-26 of 26

You may also start an advanced similarity search for this article.